Drugs / VA111913 TS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00769964 | Sep 2008 → Mar 2009 | dysmenorrhea | Vantia Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VA111913 TS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00769964 ↗ |
| Action | Inhibit | “a V1a receptor antagonist will potentially inhibit these contractions” NCT00769964 ↗ |
| Modality | Small molecule | “a new chemical entity” NCT00769964 ↗ |